The justification for Merck's marketing of vioxx was that it caused less gi side effects than other traditional NSAIDS. Merck claimed that if people used vioxx there would be less Gi side effects ending up in hospitlaizations and deaths than when using traditional pain relievers. Privately Merck consultant Loren Laine advised these claims were “bogus.”… Continue Reading